Join us from January 23-25 at the mRNA-Based Therapeutics Summit Europe 2024 - in Berlin - for an introduction by our founder, unraveling the immense potential of leveraging a commercially validated "ribosome platform".
RiboOmics Award acknowledges research achievements and cutting-edge projects by top-young scientists in the growing areas of ribosome analysis. With RiboOmics we support scientists outside conventional streamflow.
IMMAGINA, the worldโs #1 Ribosome Company, today announced the agreement with the local innovation agency to relocate to our own 1500 m2 new headquarter to meet the growing demand from our customers and collaborators.
This website uses cookies to ensure the best experience possible. More information...